Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Celina Dubin, Ester Del Duca & Emma Guttman-Yassky. (2021) The IL-4, IL-13 and IL-31 pathways in atopic dermatitis. Expert Review of Clinical Immunology 17:8, pages 835-852.
Read now
Read now
Kadra Kalamaha, Erin Reis, Shauna Newton, Conor Roche, Janet Julson, Hermina Fernandes & Jonathan Rodrigues. (2019) Atopic dermatitis: a review of evolving targeted therapies. Expert Review of Clinical Immunology 15:3, pages 275-288.
Read now
Read now
Angelo Massimiliano D’Erme, Marco Romanelli & Andrea Chiricozzi. (2017) Spotlight on dupilumab in the treatment of atopic dermatitis: design, development, and potential place in therapy. Drug Design, Development and Therapy 11, pages 1473-1480.
Read now
Read now
Articles from other publishers (25)
Sarah Thomas, Juliane E. Fiebig, Eva-Maria Kuhn, Dominik S. Mayer, Sebastian Filbeck, Werner Schmitz, Markus Krischke, Roswitha Gropp & Thomas D. Mueller. (2023) Design of Glycoengineered IL-4 Antagonists Employing Chemical and Biosynthetic Glycosylation. ACS Omega 8:28, pages 24841-24852.
Crossref
Crossref
Danielle Rogner, Tilo Biedermann & Felix Lauffer. (2022) Treatment of Atopic Dermatitis with Baricitinib: First Real-life Experience. Acta Dermato-Venereologica 102, pages adv00677.
Crossref
Crossref
Xin Tian, Qiongxiao Huang, Jingyao Liang, Jianqin Wang, Jing Zhang, Yan Yang, Qianru Ye, Suling He, Junlong Li, Zhouwei Wu & Yumei Liu. (2021)
A review of the mechanisms of keratinocytes damage caused by
Staphylococcus aureus
infection in patients with atopic dermatitis
. Journal of Leukocyte Biology 110:6, pages 1163-1169.
Crossref
Crossref
Hye-Su Park, Minseo Kang, Yong-Min Kim, Jong-Min Lim, Young Suk Kim, Hee-Taek Kim & Jae-Suk Choi. (2020) A clinical study on the efficacy and safety of the exopolymers from Aureobasidium pullulans (EAP) in subjects with mild-to-moderate atopic dermatitis. Toxicology and Environmental Health Sciences 12:1, pages 31-43.
Crossref
Crossref
Peter Florian, Klaus R. Flechsenhar, Eckart Bartnik, Danping Ding‐Pfennigdorff, Matthias Herrmann, Paul J. Bryce & Frank O. Nestle. (2019) Translational drug discovery and development with the use of tissue‐relevant biomarkers: Towards more physiological relevance and better prediction of clinical efficacy. Experimental Dermatology 29:1, pages 4-14.
Crossref
Crossref
B. W. M. Arents, U. Mensing, I. A. Seitz, N. Wettemann, A. H. Fink-Wagner, G. de Carlo, A. Zink & J. Ring. (2019) Atopic eczema score of emotional consequences—a questionnaire to assess emotional consequences of atopic eczema. Allergo Journal International 28:7, pages 277-288.
Crossref
Crossref
Bernd W. M. Arents, Ute Mensing, Irmtraud A. Seitz, Niels Wettemann, Antje-H. Fink-Wagner, Giuseppe de Carlo, Alexander Zink & Johannes Ring. (2019) Atopic eczema score of emotional consequences — a questionnaire to assess emotional consequences of atopic eczema. Allergo Journal 28:7, pages 58-69.
Crossref
Crossref
O. Yu. Olisova, D. A. Svistunova, L. M. Chernyavskaya & E. M. Anpilogova. (2019) Phosphodiesterase-4 inhibitor in the treatment of psoriasis and psoriatic arthritis. Vestnik dermatologii i venerologii 95:2, pages 74-80.
Crossref
Crossref
J. Ring, A. Zink, B.W.M. Arents, I.A. Seitz, U. Mensing, M.C. Schielein, N. Wettemann, G. Carlo & A. Fink‐Wagner. (2019)
Atopic eczema: burden of disease and individual suffering – results from a large
EU
study in adults
. Journal of the European Academy of Dermatology and Venereology 33:7, pages 1331-1340.
Crossref
Crossref
Grace Chan & Peck Y. Ong. (2019) Pathophysiology, Diagnosis, and Management of Infections in Atopic Dermatitis. Current Dermatology Reports 8:2, pages 73-79.
Crossref
Crossref
Elaine C. Siegfried, Jennifer C. Jaworski & Paola Mina-Osorio. (2018) A Systematic Scoping Literature Review of Publications Supporting Treatment Guidelines for Pediatric Atopic Dermatitis in Contrast to Clinical Practice Patterns. Dermatology and Therapy 8:3, pages 349-377.
Crossref
Crossref
Felix Lauffer, Manja Jargosch, Linda Krause, Natalie Garzorz-Stark, Regina Franz, Sophie Roenneberg, Alexander Böhner, Nikola S. Mueller, Fabian J. Theis, Carsten B. Schmidt-Weber, Tilo Biedermann, Stefanie Eyerich & Kilian Eyerich. (2018) Type I Immune Response Induces Keratinocyte Necroptosis and Is Associated with Interface Dermatitis. Journal of Investigative Dermatology 138:8, pages 1785-1794.
Crossref
Crossref
Katarzyna Osinka, Karolina Dumycz, Bartłomiej Kwiek & Wojciech Feleszko. (2017) Novel Therapeutic Approaches to Atopic Dermatitis. Archivum Immunologiae et Therapiae Experimentalis 66:3, pages 171-181.
Crossref
Crossref
Bridget P. Kaufman, Emma Guttman-Yassky & Andrew F. Alexis. (2018) Atopic dermatitis in diverse racial and ethnic groups-Variations in epidemiology, genetics, clinical presentation and treatment. Experimental Dermatology 27:4, pages 340-357.
Crossref
Crossref
S. Ferreira & T. Torres. (2018) Dupilumab for the Treatment of Atopic Dermatitis. Actas Dermo-Sifiliográficas (English Edition) 109:3, pages 230-240.
Crossref
Crossref
S. Ferreira & T. Torres. (2018) Dupilumab para el tratamiento de la dermatitis atópica. Actas Dermo-Sifiliográficas 109:3, pages 230-240.
Crossref
Crossref
Oscar Sasso, Maria Summa, Andrea Armirotti, Silvia Pontis, Claudia De Mei & Daniele Piomelli. (2018) The N-Acylethanolamine Acid Amidase Inhibitor ARN077 Suppresses Inflammation and Pruritus in a Mouse Model of Allergic Dermatitis. Journal of Investigative Dermatology 138:3, pages 562-569.
Crossref
Crossref
G I Smirnova. (2017) CURRENT CONCEPTS OF ATOPIC DERMATITIS IN CHILDREN: PROBLEMS AND PROSPECTS. Russian Journal of Allergy 14:4-5, pages 30-39.
Crossref
Crossref
Pawinee Rerknimitr, Atsushi Otsuka, Chisa Nakashima & Kenji Kabashima. (2017) The etiopathogenesis of atopic dermatitis: barrier disruption, immunological derangement, and pruritus. Inflammation and Regeneration 37:1.
Crossref
Crossref
Mark Boguniewicz, Andrew F. Alexis, Lisa A. Beck, Julie Block, Lawrence F. Eichenfield, Luz Fonacier, Emma Guttman-Yassky, Amy S. Paller, David Pariser, Jonathan I. Silverberg & Mark Lebwohl. (2017) Expert Perspectives on Management of Moderate-to-Severe Atopic Dermatitis: A Multidisciplinary Consensus Addressing Current and Emerging Therapies. The Journal of Allergy and Clinical Immunology: In Practice 5:6, pages 1519-1531.
Crossref
Crossref
Emma Guttman-Yassky, Benjamin Ungar, Kunal Malik, Daniel Dickstein, Maria Suprun, Yeriel D. Estrada, Hui Xu, Xiangyu Peng, Margeaux Oliva, Dan Todd, Tord Labuda, Mayte Suarez-Farinas & Robert Bissonnette. (2017) Molecular signatures order the potency of topically applied anti-inflammatory drugs in patients with atopic dermatitis. Journal of Allergy and Clinical Immunology 140:4, pages 1032-1042.e13.
Crossref
Crossref
Atsushi Otsuka, Takashi Nomura, Pawinee Rerknimitr, Judith A. Seidel, Tetsuya Honda & Kenji Kabashima. (2017) The interplay between genetic and environmental factors in the pathogenesis of atopic dermatitis. Immunological Reviews 278:1, pages 246-262.
Crossref
Crossref
Jeremy Udkoff, Andrea Waldman, Jusleen Ahluwalia, Jenna Borok & Lawrence F. Eichenfield. (2017) Current and emerging topical therapies for atopic dermatitis. Clinics in Dermatology 35:4, pages 375-382.
Crossref
Crossref
Matteo Megna, Maddalena Napolitano, Cataldo Patruno, Alessia Villani, Anna Balato, Giuseppe Monfrecola, Fabio Ayala & Nicola Balato. (2016) Systemic Treatment of Adult Atopic Dermatitis: A Review. Dermatology and Therapy 7:1, pages 1-23.
Crossref
Crossref
Anne Weissler. (2016) Atopic Dermatitis–A New Dawn. Physician Assistant Clinics 1:4, pages 661-682.
Crossref
Crossref